“Development Of A Box–Behnken Design Optimized Linagliptin Liposphere Formulation For Improved Bioavailability And Sustained Release”. 2025. Journal of Carcinogenesis 24 (7s): 866-77. https://doi.org/10.64149/J.Carcinog.24.7s.866-877.